Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALBIREO PHARMA, INC. has filed 1,239 SEC EDGAR filings since 28 Mar 2005

SEC filing history

Showing 576-600 of 938 matching filings.

Per page
25
Current page
24
8-K File 001-33451

8-K

Filing date
29 Jan 2016
Reporting date
29 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-33451

10-K/A

Filing date
28 Jan 2016
Reporting date
30 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
27 Jan 2016
Reporting date
21 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
25 Jan 2016
Reporting date
21 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
25 Jan 2016
Reporting date
21 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83386

SABBY 13G-A BIOD 1.11.16

Filing date
11 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83386

SEC SCHEDULE 13G

Filing date
11 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
17 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
03 Nov 2015
Reporting date
03 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
13 Oct 2015
Reporting date
06 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Oct 2015
Reporting date
30 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
25 Sep 2015
Reporting date
21 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
15 Sep 2015
Reporting date
15 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83386

SC 13G

Filing date
26 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
13 Aug 2015
Reporting date
13 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-33451

AMENDMENT TO CURRENT REPORT

Filing date
08 Jun 2015
Reporting date
02 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

CURRENT REPORT

Filing date
21 May 2015
Reporting date
15 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
19 May 2015
Reporting date
15 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
19 May 2015
Reporting date
15 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83386

SEC SCHEDULE 13G

Filing date
11 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

CURRENT REPORT

Filing date
06 May 2015
Reporting date
06 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .